Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDEA-TNF: Impact of Diet on Anti-TNF Therapy in IBD
NCT06896305Recruiting
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- May 2025
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in Crohn's disease and ulcerative colitis (UC) (2 arms), sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Efficacy of CDED in addition to anti-TNF therapy in active CD and UC versus anti-TNF therapy at 16 weeks. Started May 2025; status: recruiting.
02
Conditions
Crohn's diseaseulcerative colitis (UC)
Beyond the preview
Go deeper on NCT06896305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06896305.